Project Veritas jumped into the debate over vaccine mandates with an undercover video that shows two Pfizer scientists agreeing that naturally acquired immunity offers more protection than vaccination from the novel coronavirus.
The 10-minute video released late Monday featured three men identified as scientists at Pfizer, maker of the widely used two-dose Pfizer-BioNTech vaccine approved by the Food and Drug Administration.
A man identified as Pfizer biochemist Nick Karl was shown explaining that after recovering from COVID-19, “your antibodies are probably better at that point than the vaccination.”
“When somebody is naturally immune, like, they got COVID, they probably have better - not better, but more antibodies against the virus,” says Mr. Karl in the hidden-camera footage. “Because what the vaccine is, like I said, that protein that’s just on the outside, so it’s one antibody against one specific part of the virus.”
He went on: “When you actually get the virus, you’re going to start producing antibodies against multiple pieces of virus, and not only just like that outside portion, like, the inside portion, the actual virus.”
Concurring was a man identified as Pfizer senior associate scientist Chris Croce, who replied in the affirmative after being asked by the undercover investigator whether she had protection from COVID-19 after recovering and testing positive for the antibodies.
“As much as the vaccine?” she asked.
“Probably more,” he said.
“How much more?” she asked.
Mr. Croce replied: “You’re protected most likely for longer since it was a natural response.”
A third man identified as a Pfizer scientist Rahul Khandke said that “if you have antibodies built up, you should be able to prove that you have those,” but that’s not the pharmaceutical company’s message.
“We’re bred and taught to be like, ‘vaccine is safer than actually getting COVID,’” said Mr. Khandke. “Honestly, we had to do so many seminars on this. You have no idea. Like, we have to sit there for hours and hours and listen to like, be like, ‘you cannot talk about this in public.’”
The Washington Times has reached out to Pfizer for comment.